Interaction between TFF1, a gastric tumor suppressor trefoil protein, and TFIZ1, a brichos domain-containing protein with homology to SP-C

被引:84
作者
Westley, BR
Griffin, SM
May, FEB
机构
[1] Newcastle Univ, Royal Victoria Infirm, Dept Pathol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[2] Newcastle Univ, Sch Med, N Inst Canc Res, Sch Child & Lab Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[3] Royal Victoria Infirm, N Oesophago Gastr Canc Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
基金
英国惠康基金;
关键词
D O I
10.1021/bi047287n
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TFF1 is a gastric tumor suppressor that protects gastric epithelial cells from damage but can promote invasive properties of tumor cells. Antibodies were raised against correctly folded TFF1 protein. These showed that the 6.67 kDa secreted trefoil protein is present as an similar to 25 kDa complex in normal human gastric mucosa. The TFF1 complex was immunopurified from human gastric mucosa and shown to comprise two proteins joined by a disulfide bond. Both were identified by amino-terminal sequencing and MALDI TOF mass spectrometry. The TFF1 protein partner is a previously unknown protein that we have called TFIZ1 for trefoil factor interactions(z) 1. TFIZ1 is expressed and secreted in normal gastric mucosa. TFIZ1 mRNA was cloned from gastric mucosa and sequenced. TFIZ1 is an 18.31 kDa protein and contains an similar to 100 amino acid brichos domain and homology with smart00019.10, SF_P. This is the first demonstration that a member of the trefoil factor family of proteins is bound covalently to a brichos domain-containing protein. The apparent molecular mass of the TFF1:TFIZ1heterodimer is remarkably close to the theoretical molecular mass of 24.98 kDa. In conclusion, the heterodimer comprises one molecule each of TFF1 and TFIZ1 and the disulfide bond between TFF1 and TFIZ1is the most important factor stabilizing the heterodimer.
引用
收藏
页码:7967 / 7975
页数:9
相关论文
共 36 条
[1]   The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis [J].
Bossenmeyer-Pourié, C ;
Kannan, R ;
Ribieras, S ;
Wendling, C ;
Stoll, I ;
Thim, L ;
Tomasetto, C ;
Rio, MC .
JOURNAL OF CELL BIOLOGY, 2002, 157 (05) :761-770
[2]   DETERMINATION OF ESTROGEN RESPONSIVENESS OF BREAST-CANCER BY COMPETITIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION [J].
CARR, M ;
MAY, FEB ;
LENNARD, TWJ ;
WESTLEY, BR .
BRITISH JOURNAL OF CANCER, 1995, 72 (06) :1427-1434
[3]   Homodimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58 [J].
Chadwick, MP ;
Westley, BR ;
May, FEB .
BIOCHEMICAL JOURNAL, 1997, 327 :117-123
[4]   PRODUCTION AND COMPARISON OF MATURE SINGLE-DOMAIN TREFOIL PEPTIDES PNR-2/PS2 CYS(58) AND PNR-2/PS2 SER(58) [J].
CHADWICK, MP ;
MAY, FEB ;
WESTLEY, BR .
BIOCHEMICAL JOURNAL, 1995, 308 :1001-1007
[5]   Helicobacter pylori interacts with the human single-domain trefoil protein TFF1 [J].
Clyne, M ;
Dillon, P ;
Daly, S ;
O'Kennedy, R ;
May, FEB ;
Westley, BR ;
Drumm, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (19) :7409-7414
[6]   High expression of the trefoil protein TFF1 in interval breast cancers [J].
Crosier, M ;
Scott, D ;
Wilson, RG ;
Griffiths, CDM ;
May, FEB ;
Westley, BR .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) :215-221
[7]   Induction of scattering and cellular invasion by trefoil peptides in src- and RhoA-transformed kidney and colonic epithelial cells [J].
Emami, S ;
Le Floch, N ;
Bruyneel, E ;
Thim, L ;
May, F ;
Westley, B ;
Rio, MC ;
Mareel, M ;
Gespach, C .
FASEB JOURNAL, 2001, 15 (02) :351-361
[8]   RELATIONSHIP OF PS2 WITH RESPONSE TO TAMOXIFEN THERAPY IN PATIENTS WITH RECURRENT BREAST-CANCER [J].
FOEKENS, JA ;
PORTENGEN, H ;
LOOK, MP ;
VANPUTTEN, WLJ ;
THIRION, B ;
BONTENBAL, M ;
KLIJN, JGM .
BRITISH JOURNAL OF CANCER, 1994, 70 (06) :1217-1223
[9]   DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis [J].
Fujimoto, J ;
Yasui, W ;
Tahara, H ;
Tahara, E ;
Kudo, Y ;
Yokozaki, H ;
Tahara, E .
CANCER LETTERS, 2000, 149 (1-2) :125-134
[10]   PNR-2 PS2 IMMUNOHISTOCHEMICAL STAINING IN BREAST-CANCER - CORRELATION WITH PROGNOSTIC FACTORS AND ENDOCRINE RESPONSE [J].
HENRY, JA ;
PIGGOTT, NH ;
MALLICK, UK ;
NICHOLSON, S ;
FARNDON, JR ;
WESTLEY, BR ;
MAY, FEB .
BRITISH JOURNAL OF CANCER, 1991, 63 (04) :615-622